# Treatment of Keratoconus Using Collagen Cross-Linking

> **NCT00841386** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University at Buffalo** · enrollment: 150 (estimated)

## Conditions studied

- Keratoconus

## Interventions

- **DRUG:** Riboflavin-5-phosphate
- **DRUG:** Sham cross-linking

## Key facts

- **NCT ID:** NCT00841386
- **Lead sponsor:** University at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2009-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00841386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00841386, "Treatment of Keratoconus Using Collagen Cross-Linking". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00841386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*